NeoTherapeutics, Inc.
7Patents
0Active
7Granted
26Portfolio score
Filing activity: May 4, 1999 → Jul 6, 2001
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6630478B2 | Methods for treatment of drug-induced peripheral neuropathy | Emerging Cross-Sectional Technologies | 38 | Expired |
| US6630490B2 | Methods for treatment of disease-induced peripheral neuropathy and related conditions | Emerging Cross-Sectional Technologies | 25 | Expired |
| US6297226A | Synthesis and methods of use of 9-substituted guanine derivatives | Human Necessities | 22 | Expired |
| US6338963B1 | Use of carbon monoxide dependent guanylyl cyclase modifiers to stimulate neuritogenesis | Human Necessities | 10 | Expired |
| US6288069A | Use of 9-substituted hypoxanthine derivatives to stimulate regeneration of nervous tissue | Human Necessities | 2 | Expired |
| US6303617A | Serotonin-like 9-substituted hypoxanthine and methods of use | Human Necessities | 0 | Expired |
| US6407237B1 | Crystal forms of 9-substituted hypoxanthine derivatives | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.